Perspective Therapeutics (CATX) Insider Trading & Ownership → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free CATX Stock Alerts 1.65 +0.01 (+0.61%) (As of 12:09 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Perspective Therapeutics (NYSEAMERICAN:CATX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.52%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$57.66 MNumber OfInsiders Selling(Last 12 Months)0 Get CATX Insider Trade Alerts Want to know when executives and insiders are buying or selling Perspective Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CATX Insider Buying and Selling by Quarter Ad Banyan Hill PublishingNvidia CEO Says It Will Be “the Next Revolution” Beyond AINvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. Perspective Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/6/2024Lantheus Alpha Therapy, LlcMajor ShareholderBuy60,431,0390.9557,409,487.05 1/29/2024Robert F Williamson IIIDirectorBuy25,2660.6416,170.24 1/25/2024Robert F Williamson IIIDirectorBuy22,1340.4910,845.66 1/24/2024Markus PuhlmannInsiderBuy280,0000.50140,000.00 12/21/2023Robert F Williamson IIIDirectorBuy3,6630.331,208.79 12/18/2023Jonathan Robert HuntCFOBuy125,0000.2632,500.00 12/18/2023Markus PuhlmannInsiderBuy60,4190.2615,708.94 12/18/2023Robert F Williamson IIIDirectorBuy10,0000.262,600.00 12/15/2023Markus PuhlmannInsiderBuy135,0060.2736,451.62 (Data available from 1/1/2013 forward) CATX Insider Trading Activity - Frequently Asked Questions Who is on Perspective Therapeutics's Insider Roster? The list of insiders at Perspective Therapeutics includes Jonathan Robert Hunt, Lantheus Alpha Therapy, Llc, Markus Puhlmann, and Robert F Williamson III. Learn more on insiders at CATX. What percentage of Perspective Therapeutics stock is owned by insiders? 3.52% of Perspective Therapeutics stock is owned by insiders. Learn more on CATX's insider holdings. Which Perspective Therapeutics insiders have been buying company stock? The following insiders have purchased CATX shares in the last 24 months: Jonathan Robert Hunt (32,500.00), Lantheus Alpha Therapy, Llc (57,409,487.05), Markus Puhlmann (192,160.56), and Robert F Williamson III (30,824.69). How much insider buying is happening at Perspective Therapeutics? Insiders have purchased a total of 61,092,527 CATX shares in the last 24 months for a total of 57,664,972.30 bought. More Insider Trading Tools from MarketBeat Related Companies: MDXG Insider Buying AORT Insider Buying FNA Insider Buying KIDS Insider Buying ATRI Insider Buying ATRC Insider Buying TMCI Insider Buying SILK Insider Buying SIBN Insider Buying EMBC Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NYSEAMERICAN:CATX) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Perspective Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
